300750 CONTEMPORARY AMPEREX TECHNOLOGY CO

EQS-News: Three disruptive approaches in biotechnology and medicine win the BioRiver Boost! 2022 biotech start-up competition

EQS-News: BioRiver e.V. / Key word(s): Miscellaneous
Three disruptive approaches in biotechnology and medicine win the BioRiver Boost! 2022 biotech start-up competition

05.10.2022 / 09:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


Three disruptive approaches in biotechnology and medicine win the BioRiver Boost! 2022 biotech start-up competition

Awards go to Lumatix Biotech (1st place), BioThrust (2nd place) and Vivalyx (3rd place).

Düsseldorf/Hilden, October 5th, 2022: The winner of this year’s BioRiver Boost! competition for life science and biotech founders is Lumatix Biotech GmbH. With its light-controlled antibody purification, the start-up company from Garching, Bavaria, won first place and was voted the most promising start-up of 2022. The second and the third places went to BioThrust and Vivalyx, both based in Aachen, North Rhine-Westphalia.

In its ninth iteration, on September 29, 2022, BioRiver Boost!, selected the three best young European-based companies. A top-class jury of experts presented the awards following short company presentations and open discussion. The live event was filmed on the premises of this year’s host, QIAGEN GmbH. The three winning teams won customized coaching from experienced entrepreneurs on business development, marketing support from experts and access to the influential BioRiver network.

"The founders who apply to us inspire me every year. They deserve our support. I am very proud that BioRiver Boost! has established itself as a platform for showcasing a broad field of technologies. This year we saw innovation from a wide range of disciplines including medicine, process engineering and statistics and colorants for food and cosmetics. We enable young companies to engage in a focused exchange with experienced experts from industry," says Dr. Frauke Hangen, Managing Director of the industry association BioRiver e.V., which has been organizing the competition since 2014. "Many key representatives of the life science industry and investors interested in the sector take advantage of this opportunity to get to know the people behind the start-ups and their innovative ideas. The BioRiver network adds professional expertise for the further development of the companies."

A considerable commitment on the part of regional industry and the founders themselves is what makes BioRiver Boost! so special. Managers with life science experience from a wide range of fields contribute their know-how in dialogues, pitch trainings and as jury members to support the start-ups. This year's jury was made up of top representatives from globally active life science companies Bayer, Janssen-Cilag/Johnson&Johnson, Lonza and QIAGEN, as well as from High-Tech Gründerfonds, Heinrich Heine University and NRW.BANK.

Very young companies developing disruptive technologies or innovative services for the biotechnology or life science industry can apply for the BioRiver Boost! start-up competition. Finalists are selected on the basis of fixed criteria such as customer benefit and the degree of innovation of the technology, as well as the experience of the team and the quality of the business plan. In a two-stage process, the jury first selects eight finalists from all submissions, which then present themselves in an "elevator pitch" on the actual day of the competition and face questions from the experts.

The winning projects of this year's competition are:

1st place: Antibody purification by light

Lumatix Biotech, a young company based in Garching, produces affinity matrices for the purification of monoclonal antibodies – light-controlled and without the use of chemicals. Lumatix Biotech founder Andreas Reichert and team member Ingmar Polte accepted the award on-site saying the company intends to also use new partners from the BioRiver Network competition to bring its technology further into use. After all, he said, the prinicple can be used very broadly. Polte explained: "We can use it to purify all biomolecules – from viruses to proteins – very gently and efficiently."

Link to Lumatix Biotech's pitch presentation on 29.09.2022:

2nd place: Novel aeration of bioreactors through individual gas supply

BioThrust, a biotech start-up from Aachen, is revolutionizing the aeration of fermenters and single-use bioreactors with novel gassing solutions. BioThrust co-founders Patrick Bongartz and Konstantin Kurz had presented their project convincingly onsite, so that the jury saw first and second place very close to each other: "This is a great compliment and we are very pleased," said Kurz, whose co-founder Bongartz briefly described the technology as follows: "We ensure that no bubbles are formed in the fermenter, whose rising and bursting could tear the sensitive production cells apart."

Link to BioThrust's pitch presentation on 29.09.2022:

3rd place: Gentle organ transport without donor blood

Vivalyx, headquartered in Aachen, develops easy-to-use boxes and an innovative fluid, a blood-free, gentle perfusate, for the transport of organ donations that increase organ viability and the number of organs transported. Prof. René Tolba, co-initiator of Vivalyx, which was spun off from the University Hospital of RWTH Aachen University just two weeks ago, expressed his thanks by saying: "The prize increases our visibility and will certainly help us in the start-up phase. And it shows us that team spirit pays off. That's great!"

Link to Vivalyx's pitch presentation on 29.09.2022:
 

fncls.ssp?fn=download2_file&code_str=82e1c8032a25cf10082e038be32c38f5

Photographer: Bernd Lauter. ©BioRiver – Life Science im Rheinland e.V.,2022
The winning teams of the BioRiver Boost! 2022 (from left):
The third-place winners Dr. Benedict Doorschodt (Technical Director of Vivalyx) and Prof. Dr. René Tolba (Medical Director Vivalyx), the first-place winners Andreas Reichert (CEO of Lumatix) and Ingmar Polte (Lumatix), the second-place winners Patrick Bongartz (BioThrust) and Konstantin Kurz (BioThrust).

BioRiver was again supported by numerous sponsors this year. The host of the event was QIAGEN GmbH. Platinum sponsors were KölnBusiness Wirtschaftsförderungs-GmbH, the City of Düsseldorf, Office for Economic Development and Miltenyi Biotec. Gold sponsor was Ruhr-IP Patent attorneys. The Ministry for Economic Affairs, Innovation, Digitalization and Energy of the State of North Rhine-Westphalia sponsored the BioRiver Boost! 2022 as part of its Digital Economy NRW (#DWNRW) project.


About BioRiver – Life Science im Rheinland e. V.

The promotion of founding projects and start-ups has a long tradition in BioRiver – Life Science im Rheinland e.V. and, therefore, receives special attention. The vast majority of the more than 60 life science companies in the association, which include industry giants Bayer, LONZA, Miltenyi Biotec and QIAGEN, emerged from spin-offs from Rhineland universities. The managing directors and the management of the companies support BioRiver e.V. as chairmen, as members of the board of directors and in the working groups. In total, BioRiver has more than 110 member organizations. With the BioRiver Boost! competition, introduced 2014, BioRiver e.V. aims to further strengthen the life science industry in Rhineland as well as to provide access to leading specialists in science and industry and to promote the market entry of promising founder projects, products and processes.

For more information, please visit .

Contact:

BioRiver – Life Science im Rheinland e.V.
Dr. Frauke Hangen
Managing Director
+49 (0)211 316 0610



05.10.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


1456901  05.10.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1456901&application_name=news&site_id=research_pool
EN
05/10/2022

Underlying

300750CONTEMPORARY AMPEREX TECHNOLOGY CO

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CONTEMPORARY AMPEREX TECHNOLOGY CO

 PRESS RELEASE

EQS-News: vbw Pressemitteilung zum Koalitionsvertrag: Gute Grundlage

Emittent / Herausgeber: ibw – Informationszentrale der Bayerischen Wirtschaft e. V. / Schlagwort(e): Sonstiges/Sonstiges vbw Pressemitteilung zum Koalitionsvertrag: Gute Grundlage 10.04.2025 / 09:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. vbw zum Koalitionsvertrag: Gute Grundlage Brossardt: „Koalitionsvertrag schafft Planungssicherheit und setzt Wachstumsimpulse“  Bertram Brossardt, Hauptgeschäftsführer der vbw – Vereinigung der Bayerischen Wirtschaft e. V.: (München, 09.04.2025). Wir freuen uns, dass jetzt der Weg frei ist f...

 PRESS RELEASE

Aquis Stock Exchange - suspension of trading

Aquis Stock Exchange Aquis Stock Exchange - suspension of trading 10-Apr-2025 / 07:00 GMT/BST The issuer is solely responsible for the content of this announcement. The following securities are suspended from trading on the Aquis Growth Market from 08.00, 10 April 2025, at the request of the company: Richmond Hill Resources Plc Ordinary Shares Symbol: SHNJ ISIN: GB00BNTBWF32 The Regulation Department Aquis Stock Exchange Floor 2, 63 Queen Victoria Street, EC4N 4UA Tel: 0203 597 6361 Email:  Website:  Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The i...

 PRESS RELEASE

EQS-News: CO2Coin one of the most successful crypto investments of the...

Issuer: Clima4Future Ltd. / Key word(s): Cryptocurrency / Blockchain/Market Launch CO2Coin one of the most successful crypto investments of the coming decades. 10.04.2025 / 04:55 CET/CEST The issuer is solely responsible for the content of this announcement.     CO2Coin is going through a phase of phenomenal growth. A year ago the price was just €1, today it is around 270 USDT - an increase in value that illustrates the enormous potential of this unique project. This development reflects the crypto community's growing interest in sustainable investments. Clima4Future Lt...

 PRESS RELEASE

EQS-News: CO2Coin eine der erfolgreichsten Krypto-Investitionen der ko...

Emittent / Herausgeber: Clima4Future Ltd. / Schlagwort(e): Kryptowährung / Blockchain/Markteinführung CO2Coin eine der erfolgreichsten Krypto-Investitionen der kommenden Jahrzehnte. 10.04.2025 / 04:55 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Der CO2Coin hat einen beeindruckenden Kursanstieg erlebt. Vor einem Jahr lag der Kurs noch bei 1 €, heute liegt er bei rund 270 USDT - eine Wertsteigerung, die das enorme Potenzial dieses einzigartigen Projekts verdeutlicht. Diese Entwicklung spiegelt das wachsende Interesse der Krypto-Com...

 PRESS RELEASE

EQS-News: Zimbabwe Government Delivers on Commitment: Compensation of ...

EQS-News: Zimbabwe Ministry of Finance, Economic Development and Investment Promotion / Key word(s): Miscellaneous Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences 09.04.2025 / 20:20 CET/CEST The issuer is solely responsible for the content of this announcement. In line with the GCD agreement, the FFOs receive 1 per cent of their claim in cash, with the balance being paid through US$ denominated Treasury bonds with a 2 per cent coupon and maturities of 2 to 10 years HARARE, Zimbabwe, April 9, 2025...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch